U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
The official launch ceremony of the Farm Service Center was held with the participation of the U.S. ambassador to Armenia.
"Those events served the purpose we had set, including the issue of raising awareness of the Armenian Genocide," Vigen Sargsyan said.
“Our people have created their path to ascent through sacrifice, struggle, efforts to voice their righteous case,” Karekin II said.
Artsrun Hovhannisyan was asked to comment on Armenia’s somewhat passive reaction to the acts of aggression provoked by the adversary.
Partner news